Avitas Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$464K	Sell	1,152 -28	-2%	-$13K	0.06%	158
2024 Q3	$549K	Sell	1,180 -89	-7%	-$42.8K	0.08%	155
2024 Q2	$595K	Sell	1,269 -74	-6%	-$32.1K	0.09%	157
2024 Q1	$561K	Sell	1,343 -11	-0.8%	-$4.65K	0.09%	165
2023 Q4	$551K	Sell	1,354 -11	-0.8%	-$4.06K	0.09%	155
2023 Q3	$475K	Sell	1,365 -41	-3%	-$14.3K	0.09%	162
2023 Q2	$495K	Sell	1,406 -18	-1%	-$6.07K	0.09%	154
2023 Q1	$449K	Sell	1,424 -45	-3%	-$13.5K	0.09%	162
2022 Q4	$424K	Buy	1,469 +2	+0.1%	+$610	0.09%	154
2022 Q3	$425K	Buy	1,467 +13	+0.9%	+$3.74K	0.1%	143
2022 Q2	$410K	Buy	+1,454	New	+$389K	0.09%	153
2021 Q3	–	Sell	-5,353	Closed	-$1.08M	–	213
2021 Q2	$1.08M	Buy	5,353 +176	+3%	+$36.8K	0.19%	136
2021 Q1	$1.11M	Buy	5,177 +101	+2%	+$22.2K	0.22%	130
2020 Q4	$1.2M	Buy	5,076 +990	+24%	+$227K	0.24%	129
2020 Q3	$1.11M	Buy	4,086 +207	+5%	+$57.1K	0.31%	110
2020 Q2	$1.13M	Sell	3,879 -560	-13%	-$152K	0.37%	93
2020 Q1	$1.06M	Sell	4,439 -1,260	-22%	-$289K	0.48%	76
2019 Q4	$1.25M	Sell	5,699 -17	-0.3%	-$3.44K	0.32%	100
2019 Q3	$968K	Buy	5,716 +2,516	+79%	+$445K	0.27%	107
2019 Q2	$587K	Sell	3,200 -81	-2%	-$14.2K	0.16%	137
2019 Q1	$604K	Sell	3,281 -201	-6%	-$37.1K	0.18%	124
2018 Q4	$577K	Sell	3,482 -14	-0.4%	-$2.43K	0.19%	126
2018 Q3	$674K	Buy	3,496 +281	+9%	+$50K	0.19%	132
2018 Q2	$546K	Buy	+3,215	New	+$498K	0.17%	138